DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 82 filers reported holding DICE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.20 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,420,834 | +62.2% | 202,773 | 0.0% | 1.65% | +37.7% |
| Q1 2023 | $5,809,446 | -8.2% | 202,773 | 0.0% | 1.20% | -11.8% |
| Q4 2022 | $6,326,518 | +23.1% | 202,773 | -20.0% | 1.36% | +13.6% |
| Q3 2022 | $5,140,000 | +30.7% | 253,466 | 0.0% | 1.20% | +14.3% |
| Q2 2022 | $3,934,000 | -10.0% | 253,466 | +10.9% | 1.05% | -4.6% |
| Q1 2022 | $4,371,000 | – | 228,466 | – | 1.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northpond Ventures, LLC | 3,292,871 | $62,993,000 | 33.95% |
| Sands Capital Ventures, LLC | 3,148,970 | $60,240,000 | 12.58% |
| OUP Management Co., LLC | 536,693 | $10,267,000 | 7.82% |
| New Leaf Venture Partners, L.L.C. | 556,693 | $10,650,000 | 5.25% |
| Logos Global Management LP | 1,385,251 | $26,500,000 | 3.44% |
| Soleus Capital Management, L.P. | 983,994 | $18,824,000 | 2.43% |
| RA Capital Management | 5,208,911 | $99,646,000 | 2.17% |
| Deep Track Capital, LP | 1,250,000 | $23,913,000 | 1.53% |
| Samsara BioCapital, LLC | 228,466 | $4,371,000 | 1.10% |
| HighVista Strategies LLC | 48,960 | $937,000 | 0.60% |